Data Platform
Sign InStart a Free Trial

HCPCS J2793 Fee Schedule

Last Updated: August 2025

Injection, rilonacept, 1 mg
Login to see

Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.

Key FactDetail
Service Type

Drugs Administered Other than Oral Method

Drugs, Administered by Injection

Common Place of Service

None

99 - Other Place of Service

Common Modifiers

None

PN - Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital

Complexity LevelModerate

National average reimbursement for HCPCS J2793 by major payers:

bcbs

$26.26

uhc

$26.86

aetna

$26.64

cigna

$26.47


Find Fee Schedule & Reimbursement for Other Codes

Use our free lookup tool to explore fee schedules and reimbursement rates for any billing code. Select a code type, then type or select a code to view its details.


What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J2793. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the J2793 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

HCPCS J2793 vs. Other Drugs, Administered by Injection Codes

The HCPCS J2793 code is part of the Drugs Administered Other than Oral Method services used for Drugs, Administered by Injection. It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.

The HCPCS J2793 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.

HCPCS CodeComplexity LevelDescription
J2792Low
Injection, Rho D immune globulin, intravenous, human, solvent detergent, 100 IU
J2793Low
Injection, rilonacept, 1 mg
J2794Low
Injection, risperidone (risperdal consta), 0.5 mg

See what providers are getting paid in 2025 for J2793:

HCPCS J2793 Fee Schedule & Reimbursement Rates

The HCPCS J2793 fee schedule varies by payer type. Below are Medicare rates for 2025 and average in-network rates by state across major payers:

CodeMedicare RateAvg. Cigna National RateMore Info
J2792$36.32

Get a free sample report

J2793$26.47

Get a free sample report

J2794$11.96

Get a free sample report

Reimbursement rates depend on provider contracts, region, and payer. Always verify rates with your insurance provider or medical billing department.


What is price transparency?

The Price Transparency Rule is a federal law that took effect in July 2022, requiring all commercial payers to publicly disclose their prices through machine-readable files (MRFs). In short, this regulation mandates that insurance companies make healthcare costs transparent to the public.

Our data comes directly from these insurer-posted MRFs, ensuring compliance with the Price Transparency Rule. While PayerPrice is working toward a future where providers and payers collaborate for 100% upfront price certainty, it's important to acknowledge that data limitations and occasional errors may exist.


Unlock access to price transparency insights today.

First Name

Last Name

Email

Role / Title

Company

How did you hear about us?

PayerPrice needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.